Physician profile
James Tran
NPI 1306423330
$2,997.01
in general payments reported to CMS, 2019-2025
18 companies · $2,356 in 2025
The $2,356 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.02 · 2023: $24.49 · 2024: $592 · 2025: $2,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,321 · Travel and Lodging: $552 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,321.21 |
| Travel and Lodging | $551.79 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $951.04 | 2025 | |
| Abbvie INC. | $515.94 | 2024-2025 | |
| Amgen INC. | $442.87 | 2024-2025 | Tavneos, Evenity, Krystexxa |
| Genzyme Corporation | $263.01 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $180.87 | 2024-2025 | Tremfya |
| Janssen Biotech, INC. | $112.54 | 2024-2025 | Tremfya |
| Sanofi-Aventis U.S. LLC | $99.99 | 2025 | |
| Glaxosmithkline, LLC. | $87.80 | 2024-2025 | Benlysta |
| Aurinia Pharma U.S., INC. | $62.05 | 2024 | Lupkynis |
| Ucb, INC. | $53.10 | 2023-2024 | Cimzia |
| Alexion Pharmaceuticals, INC. | $45.73 | 2025 | Strensiq |
| E.R. Squibb & Sons, L.L.C. | $39.90 | 2025 | Sotyktu |
| Sobi, INC | $33.34 | 2025 | |
| Kyowa Kirin, INC. | $28.66 | 2025 | |
| Mallinckrodt Hospital Products INC. | $24.02 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $20.53 | 2025 | Entyvio |
| Abbott Laboratories | $19.40 | 2024 | Freestyle Libre 3 |
| Intercept Pharmaceuticals, INC. | $16.22 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.